{"id":"https://openalex.org/W3139314739","doi":"https://doi.org/10.26434/chemrxiv.14210882.v1","title":"Osteopontin (OPN) Downregulatory Alkaloid (-)-Agelastatin A Prevents Muscle Damage in a Mouse Model of Duchenne Muscular Dystrophy","display_name":"Osteopontin (OPN) Downregulatory Alkaloid (-)-Agelastatin A Prevents Muscle Damage in a Mouse Model of Duchenne Muscular Dystrophy","publication_year":2021,"publication_date":"2021-03-15","ids":{"openalex":"https://openalex.org/W3139314739","doi":"https://doi.org/10.26434/chemrxiv.14210882.v1","mag":"3139314739"},"language":"en","primary_location":{"id":"doi:10.26434/chemrxiv.14210882.v1","doi":"https://doi.org/10.26434/chemrxiv.14210882.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14210882.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.26434/chemrxiv.14210882.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016988659","display_name":"Madison Feng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madison Feng","raw_affiliation_strings":["\u2020Texas A&M University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020Texas A&M University","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077334654","display_name":"Sara Mata L\u00f3pez","orcid":"https://orcid.org/0000-0002-0280-7217","observed_orcids":["https://orcid.org/0000-0002-0280-7217"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Mata Lopez","raw_affiliation_strings":["\u2020Texas A&M University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020Texas A&M University","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003944239","display_name":"Soraya Manaviazar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soraya Manaviazar","raw_affiliation_strings":["School of Chemistry and Chemical Engineering"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry and Chemical Engineering","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071453647","display_name":"Hamish A. Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hamish A. Watson","raw_affiliation_strings":["School of Chemistry and Chemical Engineering"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry and Chemical Engineering","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015938138","display_name":"Karl J. Hale","orcid":"https://orcid.org/0000-0002-6756-8763","observed_orcids":["https://orcid.org/0000-0002-6756-8763"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karl Hale","raw_affiliation_strings":["Queen's University Belfast"],"raw_orcid":"https://orcid.org/0000-0002-6756-8763","affiliations":[{"raw_affiliation_string":"Queen's University Belfast","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071737472","display_name":"Peter P. Nghiem","orcid":"https://orcid.org/0000-0002-8796-8123","observed_orcids":["https://orcid.org/0000-0002-8796-8123"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter P Nghiem","raw_affiliation_strings":["\u2020Texas A&M University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020Texas A&M University","institution_ids":["https://openalex.org/I91045830"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12110","display_name":"Bone and Dental Protein Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteopontin","display_name":"osteopontin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/agelastatin-a","display_name":"agelastatin A","score":0.972000002861023},{"id":"https://openalex.org/keywords/alkaloids","display_name":"alkaloids","score":0.8100000023841858},{"id":"https://openalex.org/keywords/duchenne-muscular-dystrophy","display_name":"Duchenne muscular dystrophy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/exercise-induced-muscle-damage","display_name":"exercise-induced muscle damage","score":0.8479999899864197},{"id":"https://openalex.org/keywords/mdx-mice","display_name":"mdx mice","score":0.8799999952316284},{"id":"https://openalex.org/keywords/myoblasts","display_name":"myoblasts","score":0.8790000081062317},{"id":"https://openalex.org/keywords/small-molecule-drugs","display_name":"small molecule drugs","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2778943923","wikidata":"https://www.wikidata.org/wiki/Q1648484","display_name":"Duchenne muscular dystrophy","level":2,"score":0.8756853342056274},{"id":"https://openalex.org/C2780804394","wikidata":"https://www.wikidata.org/wiki/Q411994","display_name":"Osteopontin","level":2,"score":0.8412749171257019},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5588090419769287},{"id":"https://openalex.org/C2778750056","wikidata":"https://www.wikidata.org/wiki/Q24976962","display_name":"mdx mouse","level":4,"score":0.48883646726608276},{"id":"https://openalex.org/C207200792","wikidata":"https://www.wikidata.org/wiki/Q428914","display_name":"Myocyte","level":2,"score":0.44991278648376465},{"id":"https://openalex.org/C2779030066","wikidata":"https://www.wikidata.org/wiki/Q1137767","display_name":"Muscular dystrophy","level":2,"score":0.4375390410423279},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.42555931210517883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41340821981430054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3209655284881592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2573587894439697},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2493712306022644},{"id":"https://openalex.org/C2780394045","wikidata":"https://www.wikidata.org/wiki/Q412285","display_name":"Dystrophin","level":3,"score":0.14431941509246826},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.26434/chemrxiv.14210882.v1","doi":"https://doi.org/10.26434/chemrxiv.14210882.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14210882.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/21efc9c9-a68a-4908-b2da-3953d702c7da","doi":null,"is_oa":true,"landing_page_url":"https://pure.qub.ac.uk/en/publications/21efc9c9-a68a-4908-b2da-3953d702c7da","pdf_url":"https://pureadmin.qub.ac.uk/ws/files/233573402/Osteopontin_OPN_Downregulatory_Alkaloid_Agelastatin_A_Prevents_Muscle_Damage_in_a_Mouse_Model_of_Duchenne_Muscular_Dystrophy.pdf","source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"L\u00f3pez, S M, Manaviazar, S, Watson, H A, Hale, K J, Nghiem, P P & Madison Feng 2021, Osteopontin (OPN) Downregulatory Alkaloid (-)-Agelastatin A Prevents Muscle Damage in a Mouse Model of Duchenne Muscular Dystrophy. ChemRxiv. https://doi.org/10.26434/chemrxiv.14210882v1","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:figshare.com:article/14210882","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/preprint/Osteopontin_OPN_Downregulatory_Alkaloid_-_-Agelastatin_A_Prevents_Muscle_Damage_in_a_Mouse_Model_of_Duchenne_Muscular_Dystrophy/14210882","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv.14210882.v1","doi":"https://doi.org/10.26434/chemrxiv.14210882.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14210882.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W14380853","https://openalex.org/W130512251","https://openalex.org/W1153484958","https://openalex.org/W1508659364","https://openalex.org/W1846342589","https://openalex.org/W1939982746","https://openalex.org/W1964124818","https://openalex.org/W1970052195","https://openalex.org/W1982858450","https://openalex.org/W1983017262","https://openalex.org/W2038685361","https://openalex.org/W2047015778","https://openalex.org/W2052003710","https://openalex.org/W2054964759","https://openalex.org/W2066180106","https://openalex.org/W2071770148","https://openalex.org/W2082779000","https://openalex.org/W2083537465","https://openalex.org/W2098016509","https://openalex.org/W2111700646","https://openalex.org/W2141991102","https://openalex.org/W2158025124","https://openalex.org/W2336356513","https://openalex.org/W2477514514","https://openalex.org/W2739418644","https://openalex.org/W2794248935","https://openalex.org/W2911602660","https://openalex.org/W2979393210","https://openalex.org/W3001754284","https://openalex.org/W3014873060","https://openalex.org/W4229881049"],"related_works":["https://openalex.org/W4388238041","https://openalex.org/W2768206193","https://openalex.org/W2739418644","https://openalex.org/W4236052789","https://openalex.org/W2507469342","https://openalex.org/W2300439300","https://openalex.org/W4251567401","https://openalex.org/W2337139774","https://openalex.org/W2008269431","https://openalex.org/W1977510252"],"abstract_inverted_index":{"(-)-Agelastatin":[0],"A":[1],"(AA)":[2],"in":[3,10,14,31,58,92],"1,2-propanediol":[4],"(3-deoxy-DL-glycerol)":[5],"elicits":[6],"a":[7,55],"dose-dependent":[8],"decrease":[9,57],"OPN":[11,66,84],"mRNA":[12],"expression":[13],"canine":[15],"Duchenne":[16],"Muscular":[17],"Dystrophy":[18],"(DMD)":[19],"myoblasts":[20],"at":[21,38,45],"doses":[22],"ranging":[23],"from":[24],"0.01":[25],"nM-30":[26],"nM.":[27],"When":[28],"intraperitoneally":[29],"administered":[30],"the":[32,79,90],"same":[33],"vehicle":[34],"to":[35,72],"mdx":[36],"mice":[37],"2.5":[39],"mg/kg/day":[40,47],"for":[41,49],"two":[42,50],"weeks,":[43,51],"and":[44,96],"1.5":[46],"twice-weekly":[48],"(-)-AA":[52,69],"brings":[53],"about":[54],"significant":[56],"exercise-induced":[59],"muscle":[60],"damage":[61],"through":[62],"its":[63],"attenuation":[64],"of":[65,81],"expression.":[67],"Because":[68],"is":[70],"known":[71],"downregulate":[73],"OPN,":[74],"this":[75],"study":[76],"confirms":[77],"that":[78],"use":[80],"small":[82],"molecule":[83],"downregulatory":[85],"drugs":[86],"can":[87],"beneficially":[88],"modify":[89],"phenotype":[91],"DMD":[93],"animal":[94],"models":[95],"potentially":[97],"affected":[98],"boys":[99]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2021-03-29T00:00:00"}